- Home
- USEG vs KZR Comparison
USEG vs KZR Comparison
Compare USEG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- KZR
- Stock Information
- Founded
- USEG 1966
- KZR 2015
- Country
- USEG United States
- KZR United States
- Employees
- USEG N/A
- KZR N/A
- Industry
- USEG Oil & Gas Production
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- USEG Energy
- KZR Health Care
- Exchange
- USEG Nasdaq
- KZR Nasdaq
- Market Cap
- USEG 45.0M
- KZR 46.5M
- IPO Year
- USEG N/A
- KZR 2018
- Fundamental
- Price
- USEG $2.32
- KZR $6.19
- Analyst Decision
- USEG Strong Buy
- KZR Hold
- Analyst Count
- USEG 2
- KZR 2
- Target Price
- USEG $2.00
- KZR $9.00
- AVG Volume (30 Days)
- USEG 154.4K
- KZR 48.3K
- Earning Date
- USEG 11-12-2024
- KZR 03-13-2025
- Dividend Yield
- USEG N/A
- KZR N/A
- EPS Growth
- USEG N/A
- KZR N/A
- EPS
- USEG N/A
- KZR N/A
- Revenue
- USEG $22,257,000.00
- KZR N/A
- Revenue This Year
- USEG N/A
- KZR N/A
- Revenue Next Year
- USEG $12.17
- KZR N/A
- P/E Ratio
- USEG N/A
- KZR N/A
- Revenue Growth
- USEG N/A
- KZR N/A
- 52 Week Low
- USEG $0.81
- KZR $5.20
- 52 Week High
- USEG $2.43
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- USEG 73.28
- KZR 38.28
- Support Level
- USEG $1.41
- KZR $6.15
- Resistance Level
- USEG $2.43
- KZR $6.50
- Average True Range (ATR)
- USEG 0.18
- KZR 0.29
- MACD
- USEG 0.06
- KZR -0.02
- Stochastic Oscillator
- USEG 87.64
- KZR 5.13
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business activities in South Texas and the Williston Basin in North Dakota. The company generates revenue from its interest in the sales of oil and natural gas production.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.